Pharmaceutical

GS-4528 by Gilead Sciences for Metastatic Renal Cell Ca...

GS-4528 is under clinical development by Gilead Sciences and currently in Phase ...

ADRX-0706 by Adcentrx Therapeutics for Head And Neck Sq...

ADRX-0706 is under clinical development by Adcentrx Therapeutics and currently i...

BGB-30813 by BeiGene for Head And Neck Squamous Cell Ca...

BGB-30813 is under clinical development by BeiGene and currently in Phase I for ...

NT-175 by Neogene Therapeutics for Head And Neck Squamo...

NT-175 is under clinical development by Neogene Therapeutics and currently in Ph...

ORB-011 by Orionis Biosciences for Head And Neck Squamo...

ORB-011 is under clinical development by Orionis Biosciences and currently in Ph...

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

ODM-212 is under clinical development by Orion and currently in Phase I for Soli...

KB-707 by Krystal Biotech for Solid Tumor: Likelihood o...

KB-707 is under clinical development by Krystal Biotech and currently in Phase I...

RO-7566802 by Genentech USA for Solid Tumor: Likelihood...

RO-7566802 is under clinical development by Genentech USA and currently in Phase...

AWT-020 by Anwita Biosciences for Sarcomas: Likelihood ...

AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...

STAT+: The clock is ticking, and Cytokinetics is runnin...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Health data breaches hit an all-time high in 2023

At least 116 million individuals were impacted by large and numerous health data...

STAT+: BioMarin appeases an activist

Want to stay on top of the science and politics driving biotech today? Sign up t...

Devimistat by Cornerstone Pharmaceuticals for Soft Tiss...

Devimistat is under clinical development by Cornerstone Pharmaceuticals and curr...

(Nanatinostat + valganciclovir) by Viracta Therapeutics...

(Nanatinostat + valganciclovir) is under clinical development by Viracta Therape...

Enzalutamide by Pfizer for Fallopian Tube Cancer: Likel...

Enzalutamide is under clinical development by Pfizer and currently in Phase II f...

(Curcumin + doxorubicin) by Immix BioPharma for Colorec...

(Curcumin + doxorubicin) is under clinical development by Immix BioPharma and cu...